Ottawa Heart Institute Research Corporation
Clinical trials sponsored by Ottawa Heart Institute Research Corporation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- ERs test $300 quit card to kick smoking habit Results expected Sep 2026 (estimated)
- New study tests if nicotine patches and counseling can help vapers quit Results expected Oct 2026 (estimated)
- New breathing technique could uncover hidden stroke cause Results expected Oct 2026 (estimated)
- Can a sticky shield stop heart device infections? Results expected Oct 2026 (estimated)
- New ablation strategy aims to keep hearts in rhythm longer Results expected Nov 2026 (estimated)
-
Blood thinner after heart procedure: hope for artery health, but trial stopped short
Disease control Stopped earlyThis study tested whether taking the blood thinner rivaroxaban for 7 days after heart catheterization via the wrist could prevent the wrist artery from becoming blocked. About 930 adults were planned, but the trial was stopped early. The main goal was to see if the artery stayed …
Phase 3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart attack patients may get safer blood thinners tailored to their genes
Disease control Stopped earlyThis study tested whether personalizing blood-thinning drugs based on a patient's genetics and risk factors could reduce bleeding after a heart attack. It enrolled 39 patients who had already been on standard dual therapy for a year. The trial was terminated early, so the finding…
Phase 4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Tiny trial tests ablation vs. pills for heart shock prevention
Disease control Stopped earlyThis study compared two approaches to reduce shocks in people with an implantable defibrillator (ICD) who had dangerous heart rhythms. One group received antiarrhythmic drugs, the other had a catheter ablation procedure. The trial was a small pilot with only 3 participants and wa…
Phase 4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Rapid COVID test studied for emergency triage
Diagnosis Stopped earlyThis study looked at using a fast, point-of-care COVID-19 test to help doctors quickly decide how to treat patients with serious heart or breathing problems. It involved 66 adults who already tested positive for COVID-19. The goal was to find the best way to collect samples (nose…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC